Advertisement
Canada markets open in 7 hours 41 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7256
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    84.53
    +1.80 (+2.18%)
     
  • Bitcoin CAD

    85,865.77
    +1,276.09 (+1.51%)
     
  • CMC Crypto 200

    1,282.37
    +396.83 (+43.39%)
     
  • GOLD FUTURES

    2,395.70
    -2.30 (-0.10%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,370.50
    -176.75 (-1.01%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    37,195.80
    -883.90 (-2.32%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Jazz Pharmaceuticals’ 2018 Guidance and Analyst Recommendations

Jazz Pharmaceuticals’ 2018 Guidance and Analyst Recommendations

Jazz Pharmaceuticals (JAZZ) estimates that in fiscal 2018, its net revenue will be $1.86 billion–$1.93 billion. Its estimated GAAP (generally accepted accounting principles) gross margin is 93% for 2018.